City Therapeutics eyes valuation of up to $956.3 million in US IPO amid biotech listing push09/10/2026 12:13
Brief: Retension Pharmaceuticals Prices Upsized IPO Of 3.75 Million Shares At $12 Per Share09/10/2026 02:36
Last trade - 00:00Last trade - 00:00Last trade - 00:00